Accessibility Menu
CareRx logo

CareRx(TSX) CRRX

Current PriceCA$3.34
Market CapCA$212.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+11%
5 Year-46%
1 Year+17%
1 Month+1%
CareRx last closing stock price
MetricPriceDate
Last closeCAD 3.342026-07-23
CareRx stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.3%CAD 3.352026-07-16
1 month+0.6%CAD 3.322026-06-23
3 month-9.17%CAD 3.682026-04-24
Year to date-11.55%CAD 3.782025-12-31
1 year+16.97%CAD 2.862025-07-23
3 year+55.25%CAD 2.152023-07-24
5 year-46.3%CAD 6.222021-07-23
Since inception+10.51%CAD 3.032003-06-19

CareRx Financials at a Glance

Market Cap

CA$212.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$374.61M

Net Income (TTM)

CA$27.07M

EPS (TTM)

CA$0.42

P/E Ratio

7.78

Dividend

CA$0.08

Beta (Volatility)

0.37 (Low)

Price

CA$3.34

Volume

9,502

Open

CA$3.35

Previous Close

CA$3.34

Daily Range

CA$3.32 - CA$3.38

52-Week Range

CA$2.70 - CA$4.00

Estimated Earnings Date

Jul 29, 2026

CRRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CareRx

CareRx Corporation specializes in delivering tailored pharmaceutical services to Canada's senior demographic. The company operates a vast network of medication dispensing facilities, providing chronic prescriptions and advanced clinical pharmacy solutions to approximately 50,000 individuals in senior and communal living environments.

Products and Services
  • Medication dispensing for chronic prescriptions
  • Advanced clinical pharmacy solutions
  • Pharmaceutical services tailored for senior living environments
Growth Outlook
  • Revenue growth of 3.5% year-over-year in the latest quarter
  • Expansion into new senior living facilities expected to drive future growth
  • Increasing demand for specialized pharmaceutical services in aging populations
Financial Highlights
  • Recent quarterly revenue of CAD 93.9 million, reflecting strong operational performance
  • Trailing twelve months (TTM) net income margin of 7.23%, indicating profitability
  • Dividend yield of 2.39%, providing a return to shareholders
CareRx Corporation has established itself as a key player in the healthcare sector, focusing on the growing needs of the senior population in Canada. The company's commitment to providing specialized pharmaceutical services positions it well for future growth, particularly as the demand for such services continues to rise. Recent financial performance highlights a solid revenue base and profitability, which may attract potential investors looking for opportunities in the healthcare industry. The company's strategic expansion into new facilities and its ability to adapt to the evolving needs of its demographic further enhance its growth potential.
AI Generated • Jul 22, 2026

Industry

Food and Staples Retailing

Sector

Consumer Staples

Employees

1,533

CEO

Puneet Khanna

Website

www.carerx.ca

Headquarters

Toronto, ON M4R 1K8, CA

CRRX Financials

Key Financial Metrics (TTM)

Gross Margin

26.47%

Operating Margin

3.23%

Net Income Margin

7.23%

Return on Equity

27.47%

Return on Capital

6.34%

Return on Assets

10.88%

Earnings Yield

12.85%

Dividend Yield

2.39%

Payout Ratio

4.65%

Stock Overview

Market Cap

CA$212.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

63.45M

Volume

9.50K

Avg. Volume

27.39K

Financials (TTM)

Gross Profit

CA$99.18M

Operating Income

CA$12.09M

EBITDA

CA$29.93M

Operating Cash Flow

CA$28.14M

Capital Expenditure

-CA$4.61M

Free Cash Flow

CA$23.52M

Cash & ST Invst.

CA$15.32M

Total Debt

CA$78.13M

CareRx Performance Analysis

CareRx annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 381,727,00045.3%
20232023-12-31CAD 370,746,000-2.9%
20242024-12-31CAD 366,714,000-1.1%
20252025-12-31CAD 370,241,0001.0%
CareRx sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-302.1%
Q32025-09-302.0%
Q42025-12-313.1%
Q12026-03-31-2.2%
CareRx annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.7210.7%
20232023-12-31CAD -0.09-86.9%
20242024-12-31CAD -0.07-20.7%
20252025-12-31CAD 0.41N/A
CareRx sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30145.7%
Q32025-09-30177.9%
Q42025-12-311448.1%
Q12026-03-31-95.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$93.92M

+4.9%

Gross Profit

CA$23.84M

-10.3%

Gross Margin

25.38%

N/A

Market Cap

CA$212.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$138.66K

N/A

Employees

1,533

N/A

Net Income

CA$1.17M

+415.0%

EBITDA

CA$7.78M

+14.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$15.32M

+37.2%

Total Debt

CA$78.13M

-5.3%

Accounts Receivable

CA$33.46M

+2.9%

Inventory

CA$19.03M

+2.2%

Long Term Debt

CA$70.38M

-5.3%

Short Term Debt

CA$7.75M

-5.2%

Return on Assets

10.88%

N/A

Return on Invested Capital

6.55%

N/A

Free Cash Flow

CA$6.03M

+8.3%

Operating Cash Flow

CA$6.26M

-15.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LOVE.VCannara Biotech Inc.
CA$1.89+6.18%
XLY.TOAuxly Cannabis Group Inc.
CA$0.18-2.70%
PRN.TOProfound Medical Corp.
CA$9.66-2.03%
HLS.TOHLS Therapeutics Inc.
CA$4.11-2.38%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.76-0.29%
NOKNokia
$9.73-0.05%
INTCIntel
$100.23-0.02%
AALAmerican Airlines Group
$13.56-0.08%

Questions About CRRX

What is the current price of CareRx?

CareRx is trading at CA$3.34 per share.

What is the 52-week range for CareRx?

Over the past 52 weeks, CareRx has traded between CA$2.70 and CA$4.00.

How much debt does CareRx have?

As of the most recent reporting period, CareRx reported total debt of CA$78.13M.

How much cash does CareRx have on hand?

CareRx reported CA$15.32M in cash and cash equivalents in its most recent financial results.

What is CareRx’s dividend yield?

CareRx currently has a dividend yield of 2.39%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services